A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

NCT06108024 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Seborrheic Keratosis

Interventions

DRUG: SM-020 gel 1.0%
DRUG: Vehicle gel

Sponsor

DermBiont, Inc.